Their revenue numbers and gross profit numbers were great and really the only reason that the EBITDA and NPAT numbers were lower than expected was a result of restructuring costs. The salaries and employee benefits numbers were also up but this was a result of taking on additional staff as resulting from the TMS acquisition - All in all a very good result and when looking at the current market cap there is plenty of room for shareprice appreciation even without new developments.
Cheers, Manassa
JUM Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.